Clinical TrialsSearch results
Number of results: 875
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Assessment of Fractional Flow Reserve by Intravascular Ultrasound
- Stable coronary artery disease
- Kitahara Hideki
- 2019-03-18
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy(SBMA)
- Center for Clinical Trials, Japan Medical Association
- 2006-09-05
Other
- Long Term Follow-up Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy (SBMA)
- Department of Neurology, Nagoya University School of Medicine
- 2008-02-01
Recruiting
- Effective physical assessment in ITB screening trials
- Spastic paraplegia, myelitis, multiple sclerosis, cerebrovascular disease, etc.
- Murata Atsushi
- 2023-04-07
Recruiting
- Rsecue in cogunitive behavioral family therapy
- somatic symtom disorder with predominant pain
- Shimizu Eiji
- 2021-08-16
Completed
- Imagery rescripting for Chronic Pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-03-25
Recruiting
- cognitive behaviolral familly therapy for chronic pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-02-09
Recruiting
- Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET gene abnormalities
- Solid tumor (Non-small cell lung cancer, and so on)
- Masuda Noriyuki
- 2020-11-23
Completed
- Open-label, dose-escalation trial to evaluate the safety and pharmacokinetics of GEN1046 in Japanese subjects with advanced solid malignancies
- Solid tumor
- jRCT Inquiry Receipt Center
- 2021-05-25